American Hospital Association October 3, 2024

The Department of Health and Human Services Oct. 2 released final guidance detailing the process for the second cycle of negotiations under the Medicare Drug Price Negotiation Program. It also explains how the Centers for Medicare & Medicaid Services will help ensure Medicare beneficiaries can access drugs at the negotiated prices from the first and second cycles when those prices become effective in 2026 and 2027, respectively....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, HHS, Insurance, Medicare, Pharma, Pharma / Biotech
Dr. Oz, RFK Jr. on Medicare, Medicaid: 10 notes
Reading RFK Jr.’s tea leaves
New HHS leader could overhaul Medicare physician reimbursement: reports
OIG again deems HHS' infosec program ineffective
InnovationRx: Trump Picks RFK, Jr. And Dr. Oz For Key Healthcare Roles

Share This Article